Skip to main content
CDC Website

Health Professionals

Medicare and HIV/AIDS

This information sheet discusses Medicare coverage for people age 65 and older or younger people who are disabled by HIV. The information sheet explains Medicare benefits, eligibility, Medicare spending and caseload, and its future outlook. A profile of HIV/AIDS patients receiving Medicare is presented. Filling the gaps in Medicare coverage with Medicaid or other programs such as the AIDS Drug Assistance Program (ADAP).

Recommendations for Preventing Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Patients During Exposure - Prone Invasive Procedures

This report contains recommendations from CDC on preventing transmission of HIV and the Hepatitis B virus to patients during invasive procedures. It advises health care workers to follow universal precautions, which require that blood and body fluids of all patients be handled as if they contain bloodborne pathogens.

Tuberculosis: New Faces of an Old Disease

This Special Report from Medecins Sans Frontieres/Doctors Without Borders highlights the challenges, such as TB/HIV coinfection and drug resistance, faced in the fight against TB. The report also provides real-life examples of people living with TB.

MMWR: Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis

This report updates previous US Public Health Service recommendations for the management of health-care personnel (HCP) who have occupational exposure to blood and other body fluids that may contain Hepatitis B, Hepatitis C, or HIV/AIDS. It contains recommendations for Hepatitis B Virus postexposure management including initiation of hepatitis B vaccine series to any susceptible, unvaccinated person who sustains blood or body fluid exposure. Guidance is provided to clinicians and exposed HCP for selecting the appropriate HBV postexposure prophylaxis (PEP).

Roadmap for MDR-TB Scale-up: Increasing Access to MDR-TB Drugs through Innovation and Action

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.

MMWR: Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus

This report presents guidelines for identifying persons with hepatitis C virus (HCV) infection. It recommends that testing for anti-HCV should include the use of an antibody screening assay, and for screening test-positive results, a more specific supplemental assay. The guidelines expand recommendations for anti-HCV testing to include an option for reflex supplemental testing, based on screening-test-positive signal-to-cut-off ratios.

MMWR: Prevention and Control of Infections With Hepatitis Viruses in Correctional Settings

This report consolidates previous recommendations and adds new ones for preventing and controlling infections with hepatitis viruses among inmates and workers in correctional facilities. The recommendations provide guidelines for juvenile and adult correctional systems regarding (1) identification and investigation of acute viral hepatitis, (2) pre-exposure and postexposure immunization for hepatitis A and B, (3) prevention of hepatitis C virus infection and its consequences, (4) health education, and (5) release planning.

Perspectives and Practice in Antiretroviral Treatment: The Lighthouse: A Centre for Comprehensive HIV/AIDS Treatment and Care in Malawi: Case Study

This report presents the case study of the Lighthouse Trust in Malawi, which was established to provide quality care and counseling and to improve the quality of life of persons with HIV/AIDS, including the terminally ill. The report describes the objective of the Lighthouse, its services, management, staffing, funding, community involvement, building facilities, diagnostic services, antiretroviral treatment implementation, clients served, adherence support strategies, clinical outcomes, added improvements, and lessons learned.

World TB Day 2007: TB Anywhere is TB Everywhere

TB ANYWHERE IS TB EVERYWHERE is the theme for 2007 World TB Day, March 24th, offering a message of urgency and shared responsibility. The theme emphasizes that although TB is a preventable and curable disease, it remains a global emergency. It reflects the chronically inadequate investment in TB control, surveillance, research and development as well as TB's deadly synergy with HIV.
The website includes planning guidance as well as advocacy materials and resources.